Downloads provided by UsageCounts
A peer-reviewed antibody characterization article corresponding to this Zenodo preprint is openly available at F1000Research: https://doi.org/10.12688/f1000research.132249.1 Head-to-head comparison of available commercial antibodies against Profilin-1 by immunoblot (Western blot), immunoprecipitation and immunofluorescence. Work reported in this report was supported in part by the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities: the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
amyotrophic lateral sclerosis, antibody characterization, P07737, PFN1, Profilin-1, antibody validation, ALS-RAP
amyotrophic lateral sclerosis, antibody characterization, P07737, PFN1, Profilin-1, antibody validation, ALS-RAP
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 77 | |
| downloads | 25 |

Views provided by UsageCounts
Downloads provided by UsageCounts